Comparator medicines for clinical trials

In a comparative clinical trial, the comparator medicine matters as much as the investigational product: without it the study cannot start, and any uncertainty about its origin or storage conditions calls the data of the whole trial into question. Our service solves exactly that problem: comparators with verified provenance, complete documentation and delivery under controlled conditions.

The comparator sourcing challenge

Sponsors and contract research organisations (CROs) run into the same obstacles again and again: limited market availability, single-batch requirements for study consistency, minimum shelf life dictated by treatment duration, cold chain products that do not forgive transport errors and — perhaps most importantly — the need to document every link of the supply chain for the trial master file.

The European market offers a real advantage: centrally authorised products with the same composition as everywhere else in the European Union, often available at competitive cost. As an ANMDMR-authorised distributor (Wholesale Distribution Authorisation no. 716D), GDP-certified and with access to a network of licensed EU suppliers, we put that advantage to work for your trials.

What you receive, concretely

For every comparator supplied, you receive the product in the agreed batch, quantity and shelf life, together with the documentation package your file requires: certificate of analysis (CoA) where available, provenance documents evidencing the chain of custody from the licensed source, and the record of temperature conditions during storage and transport. Delivery goes to the central trial depot or, where the protocol requires, to sites — in qualified packaging, with temperature monitoring.

See also our guide to comparator sourcing for clinical trials for the full picture of the process.